Get started
MediPharm Labs Corp.MediPharm Labs Corp.MediPharm Labs Corp.

MediPharm Labs Corp.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonals

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Earnings
2026
Earnings, Q1 FY2026
May 13, 2026
Positive adjusted EBITDA and strong margins achieved amid international growth and disciplined cost control.
2025
Earnings, Q4 FY2025
Mar 30, 2026
International medical cannabis drove 8% revenue growth and margin improvement in 2025.
Earnings, Q3 FY2025
Nov 13, 2025
International medical cannabis drove 17% revenue growth, with margin recovery expected ahead.
Earnings, Q2 FY2025
Aug 14, 2025
Q2 revenue up 14% year-over-year, driven by international growth and strong cash position.
Earnings, Q1 FY2025
May 14, 2025
Record gross margin and positive EBITDA driven by surging international medical cannabis sales.
2024
Earnings, Q4 FY2024
Mar 31, 2025
Record international sales and margin gains drive MediPharm Labs near profitability.
Earnings, Q3 FY2024
Nov 14, 2024
Revenue up 15%, gross margin up 29%, and debt-free, MediPharm eyes 2025 profitability.
Earnings, Q2 FY2024
Aug 14, 2024
Record revenue and near breakeven EBITDA achieved, led by international growth and cost cuts.
Earnings, Q1 FY2024
May 15, 2024
2023
Earnings, Q4 FY2023
Mar 27, 2024
Earnings, Q3 FY2023
Nov 14, 2023
Earnings, Q2 FY2023
Aug 14, 2023
Earnings, Q1 FY2023
May 15, 2023
2022
Earnings, Q4 FY2022
Mar 31, 2023
Earnings, Q3 FY2022
Nov 14, 2022
Earnings, Q2 FY2022
Aug 15, 2022
Earnings, Q1 FY2022
May 16, 2022
2021
Earnings, Q4 FY2021
Apr 1, 2022
Earnings, Q3 FY2021
Nov 15, 2021